GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRF) » Definitions » Net Change in Cash

SPHRF (Starpharma Holdings) Net Change in Cash : $-7.87 Mil (TTM As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Starpharma Holdings Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Starpharma Holdings's Net Change in Cash for the six months ended in Jun. 2024 was $-5.82 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was $-7.87 Mil.


Starpharma Holdings Net Change in Cash Historical Data

The historical data trend for Starpharma Holdings's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Net Change in Cash Chart

Starpharma Holdings Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.73 23.28 -7.44 -9.89 -7.85

Starpharma Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.94 -3.97 -5.95 -2.04 -5.82

Starpharma Holdings Net Change in Cash Calculation

Starpharma Holdings's Net Change in Cash for the fiscal year that ended in Jun. 2024 is calculated as

Starpharma Holdings's Net Change in Cash for the quarter that ended in Jun. 2024


Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-7.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Starpharma Holdings Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.


Starpharma Holdings Business Description

Traded in Other Exchanges
Address
4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.

Starpharma Holdings Headlines

From GuruFocus

Starpharma's SPL7013 COVID-19 Nasal Spray Virucidal Against SARS-CoV-2

By Business Wire Business Wire 09-14-2020

Starpharma signs DEP� ADC Research Agreement with MSD

By PRNewswire PRNewswire 02-12-2021

Starpharma creates slow release soluble DEP remdesivir nanoparticle

By Business Wire Business Wire 09-01-2020

Starpharma Presentation Now Available for On-Demand Viewing

By PRNewswire PRNewswire 04-17-2018

Starpharma signs new DEP� agreement with MSD

By PRNewswire PRNewswire 08-10-2022

Starpharma SPL7013 Nasal Spray for COVID-19 – Development Update

By Business Wire Business Wire 08-25-2020